NCT07322783
- Conditions
- EGFR Positive Non-small Cell Lung Cancer, MET Amplification
- Locations
-
- Qingdao Central Hospital Qingdao, China
Clinical trial condition
MET Amplification
Explore clinical trials studying MET Amplification. Study availability and eligibility vary by location and protocol.
5 public trials
4 recruiting studies
MET Amplification trial results
NCT03175224
- Conditions
- Advanced Cancer, Astrocytoma, Brain Diseases, +64 more
- Locations
-
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
- Moffitt Tampa, Florida, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- University of North Carolina Chapel Hill, North Carolina, United States
NCT06109558
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Hunan Cancer Hospital Changsha, Hunan, China
NCT05800340
- Conditions
- BRAF V600 Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
- Locations
-
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guanzhou, Guangdong, China
NCT04084717
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada